Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. - Wikidata - awgldk - TriplyDB

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.

http://www.wikidata.org/entity/Q33283845

about

Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis Brain metastasis in human epidermal growth factor receptor 2-positive breast cancer: from biology to treatment Molecular interactions in the development of brain metastases PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer The vascular basement membrane as "soil" in brain metastasis Targeted Therapies for Brain Metastases from Breast Cancer Breast cancer brain metastases: biology and new clinical perspectives The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context.Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications.Role of KCNMA1 gene in breast cancer invasion and metastasis to brain.Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies.Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases.Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.Epidermal growth factor-induced heparanase nucleolar localization augments DNA topoisomerase I activity in brain metastatic breast cancer.Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer.Role of the neural niche in brain metastatic cancer.Ultrasound imaging-guided intracardiac injection to develop a mouse model of breast cancer brain metastases followed by longitudinal MRI.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition.Management of ErbB2-positive breast cancer: insights from preclinical and clinical studies with lapatinib.Pharmacologic inhibition of MLK3 kinase activity blocks the in vitro migratory capacity of breast cancer cells but has no effect on breast cancer brain metastasis in a mouse xenograft model Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.The molecular genomics of metastatic brain tumours.Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model Fluoxetine modulates breast cancer metastasis to the brain in a murine model HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis.

P2860

Q24307831-6C5A9FD8-A87A-43D1-8C05-915F5BED2034 Q24621947-0ACCE1D6-6277-41C3-AFA1-28E9D5CCC279 Q24651212-1E2BF869-11C7-4878-B8CA-AEC3100EC3E7 Q26751008-8BD45159-CCAE-4585-BE38-E8059E686D2B Q26865865-CFBE2C29-B780-47C7-B237-0F07E08A882B Q27006181-7572AD4F-3657-43CD-9A19-0AD04A670B23 Q27348725-EA27DE42-24DD-4101-9FE3-805D5423F09F Q28068154-EDACCD1D-2EE2-49FC-8201-687862730359 Q28078998-5CD6C2FC-5E3C-4117-B810-14ED5D27FE67 Q28744228-3FC5F160-522C-4A26-9FCD-E9A6BC752A06 Q29248323-7E944337-2314-4F35-8F0C-E54658A81E16 Q30238959-AD578DDE-FFD0-46A2-8B73-4983E0C321AF Q30708273-3AA052CC-BCC3-4961-94E3-7728DB301B53 Q33488361-BCB74FB3-6474-4BF2-8286-A293C80399A6 Q33519052-526F91DD-D99A-497E-BE03-F97632C8549B Q33519056-35AB040C-CC77-4992-B66F-49AC02957C49 Q33688434-313303F1-389E-4C79-9000-2A402FF21CB2 Q33805406-3DDB7BB7-8679-4E12-B94D-1079172F2C9B Q33815545-B1A0A2BA-04E5-4AC2-ABD4-D0C43C9BC1EE Q33867316-34EB9FD1-E70A-4560-9A6F-AACA83306377 Q33901255-4A2AA83B-6C5C-448D-A11C-3CEABD96EF57 Q33909294-045CAB09-CD4C-4DD5-B4D0-7A3D1C37340A Q33924093-EADB3250-2216-475A-941A-169280ED14B2 Q33924987-8D2C4918-517A-487D-A47C-8A2C32C58F28 Q33961949-BDBFFC46-C0B1-4FE9-B580-ADCE9AFC7660 Q34004215-76BED045-CEDE-4C2C-9974-8B3E7352EEDA Q34083162-6DD15DF3-ACD2-4165-8FA0-96F1233A6147 Q34119028-2F4CFAC2-B3AC-49FC-B369-5B2C996DB136 Q34173413-E85E9AA4-8623-46E6-94A3-AAF9A58E3CEB Q34222800-A6580D54-1DA7-4A44-99C4-27EDFD907873 Q34241118-0E7A31EE-46CB-49F3-B859-2285D7B1C829 Q34268838-1FF3F9A2-92FA-4EAD-A9F0-06C550514900 Q34348403-0B0AA54B-8AC6-459F-9984-77C6920D8CA5 Q34393640-E4156046-A32F-42A9-8BA4-862C6C661164 Q34499855-EAFF0725-C502-4110-8F43-388300E10492 Q34500688-9BD00891-4881-4B47-8539-950F274F904A Q34503022-67045516-E70E-4A54-A5AD-BD86D28121E8 Q34565460-B0C576A1-86BD-485C-88F3-9FB87FCEBEE7 Q34614133-534FC5BC-A72B-4797-8109-841F876C2F3E Q34690325-41520348-08B6-4849-9E0C-C6A0CC3241CF

P2860

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.

http://www.wikidata.org/entity/Q33283845

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Her-2 overexpression increases ...... ast cancer cells in the brain.

@ast

Her-2 overexpression increases ...... ast cancer cells in the brain.

@en

type

label

Her-2 overexpression increases ...... ast cancer cells in the brain.

@ast

Her-2 overexpression increases ...... ast cancer cells in the brain.

@en

prefLabel

Her-2 overexpression increases ...... ast cancer cells in the brain.

@ast

Her-2 overexpression increases ...... ast cancer cells in the brain.

@en

P1433

Q33283845-835E97C6-5DF4-41A2-95B1-3C62B457023B

P1476

Q33283845-2EBE260D-F188-4EDD-8A61-00867AD7EF64

P2093

Q33283845-24DD953C-1532-4F05-B655-CA0619BB7A72

Q33283845-5A2467A4-1940-4573-A458-08694C8FF271

Q33283845-733FAC9D-3015-405D-B7B9-9063279608EB

Q33283845-882D3676-8F4E-486A-B587-DE8F8F1DB8F0

Q33283845-9132A53F-AED5-4E47-8F36-B8441D23E393

Q33283845-91EFB064-1208-48EF-AFA3-4CE9DB74694B

Q33283845-975FC522-24A9-4D3C-B0CE-899853FD7CDA

Q33283845-999A3E9D-132E-4494-9C7E-DFF52B5424FB

Q33283845-A7EA6D3B-1489-496C-9CB2-7A782C13DDB7

Q33283845-AE8E5906-813C-4D8B-9ACD-6A2898D07915

P304

Q33283845-CBEF431E-25CF-4A2F-8A2B-8AF5869AD52A

P31

Q33283845-5F3E4D5A-192C-4873-964F-1F84C01BB889

P356

Q33283845-F7CC0EE0-9272-46B5-BC3E-FD25B83A5116

P407

Q33283845-BA724B64-EEDC-4636-8AC7-AFDD83A8DDDA

P433

Q33283845-904DF76A-D5B3-441C-B832-722B1966B120

P478

Q33283845-0ACBBCF2-3539-4311-9871-70D2AA1277AB

P577

Q33283845-35914282-0EE2-4DD5-95B3-F511909E4365

P698

Q33283845-E492F6B4-A4C3-422C-B5D7-FD74320C93D8

P921

Q33283845-6262DA96-7FFD-49A7-ABEA-9566B6CF34A9

P356

0008-5472.CAN-06-3316

P1433

Cancer Research

P1476

Her-2 overexpression increases ...... ast cancer cells in the brain.

@en

P2093

Alexander O Vortmeyer

http://www.w3.org/2001/XMLSchema#string

Andreas M Stark

http://www.w3.org/2001/XMLSchema#string

Diane Palmieri

http://www.w3.org/2001/XMLSchema#string

Douglas Halverson

http://www.w3.org/2001/XMLSchema#string

Eleazar Vega-Valle

http://www.w3.org/2001/XMLSchema#string

Jeanne M Herring

http://www.w3.org/2001/XMLSchema#string

Julie L Bronder

http://www.w3.org/2001/XMLSchema#string

Kenneth Aldape

http://www.w3.org/2001/XMLSchema#string

Lionel Feigenbaum

http://www.w3.org/2001/XMLSchema#string

Patricia S Steeg

http://www.w3.org/2001/XMLSchema#string

P304

4190-4198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-06-3316

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17483330

http://www.w3.org/2001/XMLSchema#string

P921